Insmed Incorporated (NASDAQ: INSM), a development stage company, has comprehensive expertise in protein drug development. The company has a state-of-the art FDA-approved biologic commercial manufacturing facility in Boulder, Colorado and a corporate office in Richmond Virginia. By pursuing a dual path strategy, Insmed aims to advance its proprietary protein platform into niche markets with unmet needs while entering into the follow on biologics arena. For further information, visit the Company’s web site at www.insmed.com.
- 17 years ago
QualityStocks
Insmed Incorporated (NASDAQ: INSM)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – BluSky AI Inc. (OTC: BSAI) Launches SkyMod Series for Scalable, Rapid-Deploy AI Datacenters
BluSky AI (OTC: BSAI) announced the completion of its modular AI datacenter infrastructure, unveiling the…
-
Newton Golf Company Inc. (NASDAQ: NWTG) Unveils Lighter Shaft amid Women’s Golf Boom
Women make up roughly 28% of on-course golfers in the United States, a historic high.…
-
Soligenix Inc. (NASDAQ: SNGX) Makes Advancement in Proprietary Treatment for Behçet’s Disease
Behçet’s disease is more prevalent in countries along the Silk Road, including Türkiye, Iran and…